XCUR - Exicure Inc logo

XCUR

Exicure Inc

Exicure Inc develops nucleic acid therapies targeting neurological disorders, immuno-oncology, and inflammation. The company utilizes proprietary spherical nucleic acid technology to create innovative treatments for various medical conditions.

โš•๏ธ Healthcare NASDAQ Listed 2018 $ USD
$1,000 invested 5 years ago โ†’$7today

Score Overview

1 Year
Score
Net Growth49.02%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth-100.00%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score4.9
Net Growth79.95%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth-100.00%
Rev Trend40%
Revenue Consistencyโ€”
All Time
Score
Net Growth77.93%
Net Trend57%
Net Income Consistency
Rev Growth-100.00%
Rev Trend57%
Revenue Consistency

See the full market ranking โ†’

Exicure Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 16M to $ 0.00 and net income went from -$ 24M to -$ 4M. Revenue increased in 2 of those 5 years; net income in 3.

Exicure Inc currently holds a 5-year HDB Score of 4.9 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.30โ€”
1 Year2025-08-12
$ 7.30-82.19%
5 Years2021-08-12
$ 183.00-99.29%
All Time2018-05-22
$ 465.00-99.72%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2025$ 0.00-$ 4M$ 3M
2024$ 500K-$ 9M$ 12M
2023$ 0.00-$ 16M$ 816K
2022$ 28M-$ 2M$ 8M
2021-$ 483K-$ 64M$ 39M
2020$ 16M-$ 24M$ 82M
2019$ 1M-$ 26M$ 110M
IPO2018$ 118K-$ 22M$ 26M

Explore beyond XCUR

You're looking at Exicure Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies